After a slow couple of years, there are signs that biotech M&A activity is coming back into vogue, and a series of small transactions announced in the last few days pr
Sewage monitoring is being trialled as a way to spot new outbreaks of coronavirus, and three UK companies have now joined forces to try to develop a probe for this purpose.
Dr Amrik Basran from Avacta explains the current state of cancer immunotherapy and the challenges of moving into combinations of these innovative treatments.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh